Evaluation of Efficacy and Safety of SDN-037
Public ClinicalTrials.gov record NCT03426267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Parallel Group, Multicenter, Study To Evaluate Efficacy And Safety of SDN -037 Twice Daily Compared With Vehicle For The Treatment Of Inflammation And Pain Associated With Ocular Surgery.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.
Study identification
- NCT ID
- NCT03426267
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 325 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 27, 2018
- Primary completion
- Mar 4, 2020
- Completion
- Mar 4, 2020
- Last update posted
- May 16, 2021
2018 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SPARC Site 13 | Chandler | Arizona | 85224 | — |
| SPARC Site 14 | Mesa | Arizona | 85208 | — |
| SPARC Site 11 | Prescott | Arizona | 86301 | — |
| SPARC Site 12 | Sun City | Arizona | 85351 | — |
| SPARC site 01 | Fayetteville | Arkansas | 72704 | — |
| SPARC Site 10 | Santa Barbara | California | 93110 | — |
| SPARC Site 08 | Colorado Springs | Colorado | 80919 | — |
| SPARC Site 06 | Coral Springs | Florida | 33067 | — |
| SPARC Site 18 | Fort Myers | Florida | 33901 | — |
| SPARC Site 16 | Jacksonville | Florida | 32204 | — |
| SPARC Site 07 | Miami | Florida | 33143 | — |
| SPARC Site 15 | Paducah | Kentucky | 42001 | — |
| SPARC Site 05 | Saint Joseph | Michigan | 49085 | — |
| SPARC Site 09 | Henderson | Nevada | 89052 | — |
| SPARC Site 03 | Poughkeepsie | New York | 12603 | — |
| SPARC Site 04 | Winston-Salem | North Carolina | 27101 | — |
| SPARC Site 17 | Fargo | North Dakota | 58103 | — |
| SPARC Site 19 | Austin | Texas | 78731 | — |
| SPARC Site 2 | Mission | Texas | 78572 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03426267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2021 · Synced Sep 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03426267 live on ClinicalTrials.gov.